Saurabh Saha - 31 Dec 2022 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Executive Officer, Director
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
31 Dec 2022
Net transactions value
-$136,478
Form type
4
Filing time
04 Jan 2023, 18:25:04 UTC
Previous filing
06 Jul 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Tax liability $136,478 -44,025 -5.9% $3.10 705,975 31 Dec 2022 Direct F1, F2
holding CNTA Ordinary Shares 38,000 31 Dec 2022 By trust F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
F3 These shares are held directly in a trust, for which the reporting person and his spouse serve as trustees.